Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Chinese Patent Office
Cantor Fitzgerald
Boehringer Ingelheim
Covington
Moodys
Johnson and Johnson
Healthtrust

Generated: April 22, 2018

DrugPatentWatch Database Preview

CYCLAFEM 0.5/35 Drug Profile

« Back to Dashboard

When do Cyclafem 0.5/35 patents expire, and when can generic versions of Cyclafem 0.5/35 launch?

Cyclafem 0.5/35 is a drug marketed by Vintage Pharms and is included in one NDA.

The generic ingredient in CYCLAFEM 0.5/35 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for CYCLAFEM 0.5/35
Drug patent expirations by year for CYCLAFEM 0.5/35

US Patents and Regulatory Information for CYCLAFEM 0.5/35

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage Pharms CYCLAFEM 0.5/35 ethinyl estradiol; norethindrone TABLET;ORAL-28 203413-001 Dec 16, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
Harvard Business School
Chubb
US Department of Justice
McKesson
Citi
Mallinckrodt
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.